MEDIA, Pa., Jan. 10 /PRNewswire-FirstCall/ -- Synova Healthcare, Inc., a wholly owned subsidiary of Synova Healthcare Group, Inc. , today announced that it has entered into an exclusive five-year distribution and supply agreement with Common Sense, Ltd., a company based in Israel that specializes in the development and manufacture of diagnostic products for women’s health care. Under this agreement, Common Sense will supply Synova with products utilizing their technology which will complement Synova’s developing female healthcare product line.
Synova specializes in the development and distribution of non-invasive medical diagnostics to both the retail and professional market segments. The Company’s current products, Menocheck(R) and MenocheckPro(TM), are respectively over-the-counter and point-of-care/professional use non-invasive diagnostic tests that are useful for detecting the onset of menopause. In early 2006, Synova plans to utilize the Common Sense technology to introduce a non-invasive at-home test that will indicate whether users need to seek professional care for infections such as Bacterial Vaginosis or Trichomonas. Synova recently announced similar plans for the introduction of an infertility diagnostic, and also continues to develop a novel, non-invasive fetal monitor.
Mr. Menashe Tarem, CEO and Managing Director of Common Sense, Ltd., said, “We are very pleased with the signing of this agreement with Synova, and to see our product technology which is already available in Europe being introduced in the USA.” Mr. Stephen King, CEO of Synova, stated, “We look forward to continuing our commitment to our customers and shareholders, by delivering a portfolio of leading-edge products to both the retail and professional point-of-care marketplace, through collaboration with valued research and development partners like Common Sense. We are looking forward to continued collaboration between our companies.”
About Synova Healthcare Group, Inc.:
Synova Healthcare Group, Inc., (SNVH), presently operates two wholly owned subsidiaries: Synova Healthcare, Inc. and Synova Pre-Natal Healthcare, Inc. The company distributes rapid, non-invasive medical diagnostics to retail for over-the-counter (OTC) use, and directly to health care providers for point-of-care (POC) use in the clinical setting. The company’s products are designed to improve human health and quality of life by providing early and accurate awareness of the onset of certain medical conditions.
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “potential” and similar expressions. These statements reflect the Company’s current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company’s actual results, performance or achievements to differ materially from those expressed in or implied by such statements. There can be no assurance that such factors will not affect the accuracy of such forward-looking statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information set forth in this Press Release including such forward-looking statements. This press release does not constitute an offer to sell or the solicitation of an offer to buy; nor will there be any sale of securities of Synova Healthcare Group, Inc. in any state where such offer, solicitation or sale would be unlawful before registration or qualification under the securities laws of those states.
Corporate Contact Information: Synova Healthcare Group, Inc Attn: Mr. Robert Edwards, CFO 1400 N. Providence Road, Ste. 6010 Media, PA 19063 Tel: 610-565-7080 Fax: 610-565-7081 http://www.synovahealthcare.com Inquiries may also be directed to: info@synovahealthcare.com
Synova Healthcare Group, Inc.
CONTACT: Robert Edwards, CFO, Synova Healthcare Group, +1-610-565-7080 orFax: +1-610-565-7081 or info@synovahealthcare.com
Web site: http://www.synovahealthcare.com//
